Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discovery

Heavy chain-only antibodies have found many applications where conventional heavy-light heterodimeric antibodies are not favorable. Heavy chain-only antibodies with their single antigen-binding domain offer the advantage of a smaller size and higher stability relative to conventional antibodies, and...

Full description

Saved in:
Bibliographic Details
Main Authors: Christine N. Vuong, Kevin M. Reynolds, Gerry S. Rivera, Baisen Zeng, Zahra Karimpourkalou, Manith Norng, Yulei Zhang, Robayet Chowdhury, Darlene Pedersen, Melissa Pantoja, Ellen Collarini, Swetha Garimalla, Shelley Izquierdo, Eric G. Vajda, Brett Antonio, Devendra B. Srivastava, Marie-Cecile van de Lavoir, Yasmina Abdiche, William Harriman, Philip A. Leighton
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:mAbs
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19420862.2024.2435476
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576583394656256
author Christine N. Vuong
Kevin M. Reynolds
Gerry S. Rivera
Baisen Zeng
Zahra Karimpourkalou
Manith Norng
Yulei Zhang
Robayet Chowdhury
Darlene Pedersen
Melissa Pantoja
Ellen Collarini
Swetha Garimalla
Shelley Izquierdo
Eric G. Vajda
Brett Antonio
Devendra B. Srivastava
Marie-Cecile van de Lavoir
Yasmina Abdiche
William Harriman
Philip A. Leighton
author_facet Christine N. Vuong
Kevin M. Reynolds
Gerry S. Rivera
Baisen Zeng
Zahra Karimpourkalou
Manith Norng
Yulei Zhang
Robayet Chowdhury
Darlene Pedersen
Melissa Pantoja
Ellen Collarini
Swetha Garimalla
Shelley Izquierdo
Eric G. Vajda
Brett Antonio
Devendra B. Srivastava
Marie-Cecile van de Lavoir
Yasmina Abdiche
William Harriman
Philip A. Leighton
author_sort Christine N. Vuong
collection DOAJ
description Heavy chain-only antibodies have found many applications where conventional heavy-light heterodimeric antibodies are not favorable. Heavy chain-only antibodies with their single antigen-binding domain offer the advantage of a smaller size and higher stability relative to conventional antibodies, and thus, the potential for novel targeting modalities. Domain antibodies have commonly been sourced from camelids with ex-vivo humanization or transgenic rodents expressing heavy chains without light chains, but these host species are all mammalian, limiting their capacity to elicit robust immune responses to conserved mammalian targets. We have developed transgenic chickens expressing heavy chain-only antibodies with a human variable region to combine the superior target recognition advantages of a divergent, non-mammalian host with the ability to discover single-domain binders. These birds produce robust immune responses, consisting of antigen-specific antibodies targeting diverse epitopes with a range of affinities. Biophysical attributes are favorable, with good developability profiles and low predicted immunogenicity.
format Article
id doaj-art-e1ab1681fce44c14a4eb463c71ee1174
institution Kabale University
issn 1942-0862
1942-0870
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series mAbs
spelling doaj-art-e1ab1681fce44c14a4eb463c71ee11742025-01-31T04:19:38ZengTaylor & Francis GroupmAbs1942-08621942-08702024-12-0116110.1080/19420862.2024.2435476Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discoveryChristine N. Vuong0Kevin M. Reynolds1Gerry S. Rivera2Baisen Zeng3Zahra Karimpourkalou4Manith Norng5Yulei Zhang6Robayet Chowdhury7Darlene Pedersen8Melissa Pantoja9Ellen Collarini10Swetha Garimalla11Shelley Izquierdo12Eric G. Vajda13Brett Antonio14Devendra B. Srivastava15Marie-Cecile van de Lavoir16Yasmina Abdiche17William Harriman18Philip A. Leighton19OmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAOmniAb, Inc, Emeryville, CA, USAHeavy chain-only antibodies have found many applications where conventional heavy-light heterodimeric antibodies are not favorable. Heavy chain-only antibodies with their single antigen-binding domain offer the advantage of a smaller size and higher stability relative to conventional antibodies, and thus, the potential for novel targeting modalities. Domain antibodies have commonly been sourced from camelids with ex-vivo humanization or transgenic rodents expressing heavy chains without light chains, but these host species are all mammalian, limiting their capacity to elicit robust immune responses to conserved mammalian targets. We have developed transgenic chickens expressing heavy chain-only antibodies with a human variable region to combine the superior target recognition advantages of a divergent, non-mammalian host with the ability to discover single-domain binders. These birds produce robust immune responses, consisting of antigen-specific antibodies targeting diverse epitopes with a range of affinities. Biophysical attributes are favorable, with good developability profiles and low predicted immunogenicity.https://www.tandfonline.com/doi/10.1080/19420862.2024.2435476Heavy chain-onlysdabsingle-domain antibodytransgenic chickenVHH
spellingShingle Christine N. Vuong
Kevin M. Reynolds
Gerry S. Rivera
Baisen Zeng
Zahra Karimpourkalou
Manith Norng
Yulei Zhang
Robayet Chowdhury
Darlene Pedersen
Melissa Pantoja
Ellen Collarini
Swetha Garimalla
Shelley Izquierdo
Eric G. Vajda
Brett Antonio
Devendra B. Srivastava
Marie-Cecile van de Lavoir
Yasmina Abdiche
William Harriman
Philip A. Leighton
Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discovery
mAbs
Heavy chain-only
sdab
single-domain antibody
transgenic chicken
VHH
title Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discovery
title_full Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discovery
title_fullStr Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discovery
title_full_unstemmed Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discovery
title_short Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discovery
title_sort heavy chain only antibodies with a stabilized human vh in transgenic chickens for therapeutic antibody discovery
topic Heavy chain-only
sdab
single-domain antibody
transgenic chicken
VHH
url https://www.tandfonline.com/doi/10.1080/19420862.2024.2435476
work_keys_str_mv AT christinenvuong heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT kevinmreynolds heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT gerrysrivera heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT baisenzeng heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT zahrakarimpourkalou heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT manithnorng heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT yuleizhang heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT robayetchowdhury heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT darlenepedersen heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT melissapantoja heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT ellencollarini heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT swethagarimalla heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT shelleyizquierdo heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT ericgvajda heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT brettantonio heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT devendrabsrivastava heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT mariececilevandelavoir heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT yasminaabdiche heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT williamharriman heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery
AT philipaleighton heavychainonlyantibodieswithastabilizedhumanvhintransgenicchickensfortherapeuticantibodydiscovery